Search research articles
Contact Us
Filters
Showing results (21-30 of 168) with videos related to
Page
of 17
Sort By:
Trends in Pharmacological Sciences
|
September 29, 2006
Can personalized drug therapy be achieved? A closer look at pharmaco-metabonomics
Daniel W Nebert, Elliot S Vesell
Nature Reviews. Cancer
|
November 28, 2006
The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis
Daniel W Nebert, Timothy P Dalton
Human Genomics
|
December 17, 2004
The truth about mouse, human, worms and yeast
David R Nelson, Daniel W Nebert
Lancet (London, England)
|
October 22, 2002
Clinical importance of the cytochromes P450
Daniel W Nebert, David W Russell
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
May 27, 2011
Genetic architecture of susceptibility to PCB126-induced developmental cardiotoxicity in zebrafish
Eric R Waits, Daniel W Nebert
European Journal of Pharmacology
|
October 7, 2004
Advances in pharmacogenomics and individualized drug therapy: exciting challenges that lie ahead
Daniel W Nebert, Elliot S Vesell
Human Genomics
|
June 25, 2026
Replicating lipid micelles: a feasible precursor to the origin of life and the earliest appearance of genomes
Daniel W Nebert, Zijuan Liu, Vasilis Vasiliou
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
January 26, 2018
Cytochrome P450 1A1 (CYP1A1) protects against nonalcoholic fatty liver disease caused by Western diet containing benzo[a]pyrene in mice
Shigeyuki Uno, Daniel W Nebert, Makoto Makishima
Human Genomics
|
May 1, 2009
Human ATP-binding cassette (ABC) transporter family
Vasilis Vasiliou, Konstandinos Vasiliou, Daniel W Nebert
Human Genomics
|
January 9, 2009
Update on the olfactory receptor (OR) gene superfamily
Tsviya Olender, Doron Lancet, Daniel W Nebert
Page
of 17
Search research articles
Search
Showing results (21-30 of 168) with videos related to
Sort By:
Page
of 17
Trends in Pharmacological Sciences
|
September 29, 2006
Can personalized drug therapy be achieved? A closer look at pharmaco-metabonomics
Daniel W Nebert, Elliot S Vesell
Nature Reviews. Cancer
|
November 28, 2006
The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis
Daniel W Nebert, Timothy P Dalton
Human Genomics
|
December 17, 2004
The truth about mouse, human, worms and yeast
David R Nelson, Daniel W Nebert
Lancet (London, England)
|
October 22, 2002
Clinical importance of the cytochromes P450
Daniel W Nebert, David W Russell
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
May 27, 2011
Genetic architecture of susceptibility to PCB126-induced developmental cardiotoxicity in zebrafish
Eric R Waits, Daniel W Nebert
European Journal of Pharmacology
|
October 7, 2004
Advances in pharmacogenomics and individualized drug therapy: exciting challenges that lie ahead
Daniel W Nebert, Elliot S Vesell
Human Genomics
|
June 25, 2026
Replicating lipid micelles: a feasible precursor to the origin of life and the earliest appearance of genomes
Daniel W Nebert, Zijuan Liu, Vasilis Vasiliou
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
January 26, 2018
Cytochrome P450 1A1 (CYP1A1) protects against nonalcoholic fatty liver disease caused by Western diet containing benzo[a]pyrene in mice
Shigeyuki Uno, Daniel W Nebert, Makoto Makishima
Human Genomics
|
May 1, 2009
Human ATP-binding cassette (ABC) transporter family
Vasilis Vasiliou, Konstandinos Vasiliou, Daniel W Nebert
Human Genomics
|
January 9, 2009
Update on the olfactory receptor (OR) gene superfamily
Tsviya Olender, Doron Lancet, Daniel W Nebert
Page
of 17